HRTXHeron Therapeutics, Inc.

$153M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+2305.6% YoY

Gross Profit

$26M85.1% margin

Operating Income

-$195M-632.4% margin

Net Income

-$197M-641.9% margin

EPS (Diluted)

$-3.65

Cash Flow

Operating Cash Flow

-$170M

Free Cash Flow

-$173M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$234M

Total Liabilities

$103M

Stockholders' Equity

$131M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$1M	+2305.6%
Gross Profit	$26M	$1M	+2004.4%
Operating Income	-$195M	-$171M	-13.8%
Net Income	-$197M	-$173M	-14.1%

HRTX FY 2017 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena